XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
WARRANTS AND PREFERRED STOCKS
12 Months Ended
Dec. 31, 2023
WARRANTS AND PREFERRED STOCKS  
WARRANTS AND PREFERRED STOCKS

NOTE 6  WARRANTS AND PREFERRED STOCK:

 

Warrants

 

2023 Extension of Warrant Terms

 

The Company, acting by resolution of its Board of Directors, amended and extended the expiration date of its outstanding warrants to purchase up to 6,909,000 shares of common stock to March 7, 2026. The terms of the warrants, including the exercise price of $0.15 per share, remain in effect without modification. The warrants modification expense of $345,450 was recorded as the incremental value of the modified warrants over the unmodified warrants on the modification date. Assumptions used in the Black Scholes option-pricing model for these warrants were as follows:

 

Average risk-free interest rate

 

 

4.66%

Average expected life-years

 

 

3

 

Expected volatility

 

 

182.19%

Expected dividends

 

 

0%

 

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

6,909,000

 

 

$0.15

 

 

 

0.18

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Extended

 

 

6,909,000

 

 

 

0.15

 

 

 

3.00

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited/expired

 

 

(6,909,000 )

 

 

0.15

 

 

 

-

 

Outstanding at December 31, 2023

 

 

6,909,000

 

 

$0.15

 

 

 

2.18

 

Exercisable at December 31, 2023

 

 

6,909,000

 

 

$0.15

 

 

 

2.18

 

As of December 31, 2023 and December 31, 2022, the average remaining contractual life of the outstanding warrants was 2.18 years and 0.18 year, respectively. The warrants will expire on March 7, 2026. The intrinsic value of the warrants at December 31, 2023 was $0 due to the exercise price exceeding the fair market value of the common stock.

 

Series A 10% Convertible Preferred Stock

 

The Company has authorized 4,000,000 shares of Preferred Stock, of which 50,000 shares have been designated as Series A 10% Convertible Preferred Stock.  As of December 31, 2023 and 2022 there was no Preferred Stock issued or outstanding.